CW May 2004

category image Volume 13
Issue Number 5
May 2004
ISSN 10593802

New Agents Target Tumor Angiogenesis

Several new or experimental tumor anti-angiogenesis agents show promise in clinical trials, particularly for patients with renal cell carcinoma (RCC).
Go to Previous Page
Go to Next Page

Source & Additional Reading

Lee Ellis of MD Anderson Cancer Center in Houston, TX.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW May 2004

Purchase Downloadable Full-text PDF of Complete Issue: $20.00

Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login

Mountain Media ecommerce solutions Ecommerce Solutions by Mountain Media